Collectively, these findings establish APOE ε4 as a major pathogenic driver in AD, orchestrating both its initiation and progression through multiple synergistic mechanisms, including accelerated amyloidogenesis, synaptic dysfunction, and impaired neuronal signaling. The gene discussed is APOE; the disease is Alzheimer disease.